5f6a4bcfe068e344c2993e54bf1c012b

1. HBA1C (GLYCATED HEMOGLOBIN) RAPID QUANTITATIVE TEST (IMMUNOFLUORESCENCE ASSAY) / HBA1C (HEMOGLOBINA GLICOSILADA) PRUEBA RAPIDA CUANTITATIVA (PRUEBA DE INMUNOENSAYO

DISTRIBUIDORA Y COMERCIALIZADORA DIZAR LTDA.·II·Colombia INVIMA·Expires March 26, 2034

Device classification

Risk class / Clase de Riesgo: II
Product type (Spanish): REACTIVO DIAGNOSTICO
Product type (English): DIAGNOSTIC REAGENT

Registration information

Analysis ID: 5f6a4bcfe068e344c2993e54bf1c012b
Expire date: March 26, 2034

Authorized company / Fabricante

Name (Spanish): DISTRIBUIDORA Y COMERCIALIZADORA DIZAR LTDA.
Name (English): DISTRIBUTOR AND MARKETER DIZAR LTDA.

Product use / Uso del Producto

Spanish

DETERMINACIÓN DE LOS DIFERENTES ANALITOS RELACIONADOS CON MUESTRAS PROCEDENTES DEL ORGANISMO HUMANO

English

DETERMINATION OF THE DIFFERENT ANALYTES RELATED TO SAMPLES FROM THE HUMAN ORGANISM

About this record

Access comprehensive regulatory information for 1. HBA1C (GLYCATED HEMOGLOBIN) RAPID QUANTITATIVE TEST (IMMUNOFLUORESCENCE ASSAY) / HBA1C (HEMOGLOBINA GLICOSILADA) PRUEBA RAPIDA CUANTITATIVA (PRUEBA DE INMUNOENSAYO (1. HBA1C (GLYCATED HEMOGLOBIN) RAPID QUANTITATIVE TEST (IMMUNOFLUORESCENCE ASSAY) / HBA1C (HEMOGLOBINA GLICOSILADA) PRUEBA RAPIDA CUANTITATIVA (PRUEBA DE INMUNOENSAYO) in the Colombia medical device market through Pure Global AI's free database. This II medical device is registered under INVIMA analysis ID 5f6a4bcfe068e344c2993e54bf1c012b and manufactured by DISTRIBUIDORA Y COMERCIALIZADORA DIZAR LTDA.. The device was registered on March 26, 2034.

This page provides complete registration details including product type (DIAGNOSTIC REAGENT), authorised information, and regulatory compliance data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.